Neuroone Medical Technologies (NMTC) EBIAT (2016 - 2025)
Historic EBIAT for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to -$1.4 million.
- Neuroone Medical Technologies' EBIAT fell 18053.95% to -$1.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.8 million, marking a year-over-year increase of 499.87%. This contributed to the annual value of -$3.6 million for FY2025, which is 7073.11% up from last year.
- Neuroone Medical Technologies' EBIAT amounted to -$1.4 million in Q4 2025, which was down 18053.95% from -$1.6 million recorded in Q3 2025.
- In the past 5 years, Neuroone Medical Technologies' EBIAT registered a high of $1.8 million during Q4 2024, and its lowest value of -$3.5 million during Q1 2023.
- In the last 5 years, Neuroone Medical Technologies' EBIAT had a median value of -$2.8 million in 2022 and averaged -$2.4 million.
- In the last 5 years, Neuroone Medical Technologies' EBIAT soared by 15337.45% in 2024 and then crashed by 18053.95% in 2025.
- Quarter analysis of 5 years shows Neuroone Medical Technologies' EBIAT stood at -$2.8 million in 2021, then soared by 38.28% to -$1.7 million in 2022, then plummeted by 93.04% to -$3.3 million in 2023, then skyrocketed by 153.37% to $1.8 million in 2024, then plummeted by 180.54% to -$1.4 million in 2025.
- Its EBIAT was -$1.4 million in Q4 2025, compared to -$1.6 million in Q3 2025 and -$1.5 million in Q2 2025.